{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T04:23:19Z","timestamp":1750220599216,"version":"3.40.4"},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"21","license":[{"start":{"date-parts":[[2021,5,28]],"date-time":"2021-05-28T00:00:00Z","timestamp":1622160000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"crossref","award":["HI15C0001"],"award-info":[{"award-number":["HI15C0001"]}],"id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>Anti-angiotensin II type 1 receptor antibodies (AT<jats:sub>1<\/jats:sub>R-Abs) have been demonstrated to increase the risk of antibody-mediated rejection. We report a case of AT<jats:sub>1<\/jats:sub>R-Ab mediated rejection which caused early critical cortical infarction.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns:<\/jats:title>\n            <jats:p>A 52-year-old man with end-stage kidney disease underwent preemptive kidney transplantation (KT) from his wife. He had no immunologic risk except ABO incompatibility. Proper desensitization treatment were applied prior to KT. On postoperative day 1, he showed stable clinical course with adequate urine output, but there was no decrease in serum creatinine level and imaging studies showed hypoperfusion in the transplanted kidney.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnoses:<\/jats:title>\n            <jats:p>Allograft biopsy revealed total cortical infarction with severe necrotizing vasculitis, but the medullary area was preserved. Serum AT<jats:sub>1<\/jats:sub>R-Ab concentration was elevated from 10.9\u200aU\/mL before KT to 19.1\u200aU\/mL on 7\u200adays after KT.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>He was treated with plasmapheresis, intravenous immunoglobulin, rituximab, high-dose methylprednisolone, and bortezomib.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>The treatment showed a partial response, and he was discharged with 7.3\u200amg\/dL creatinine level. At 4\u200amonths, his creatinine plateaued at 5.5\u200amg\/dL and AT<jats:sub>1<\/jats:sub>R-Ab decreased to 3.6\u200aU\/mL.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons:<\/jats:title>\n            <jats:p>This case highlights the risk of early active antibody-mediated rejection by preformed AT<jats:sub>1<\/jats:sub>R-Ab, suggesting its ability to exhibit atypical histopathologic findings, such as total cortical infarction.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000025958","type":"journal-article","created":{"date-parts":[[2021,5,25]],"date-time":"2021-05-25T15:51:07Z","timestamp":1621957867000},"page":"e25958","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Early critical cortical infarction by anti-angiotensin II type 1 receptor antibody"],"prefix":"10.1097","volume":"100","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5517-9886","authenticated-orcid":false,"given":"Jeong-Hoon","family":"Lim","sequence":"first","affiliation":[{"name":"Department of Internal Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8856-553X","authenticated-orcid":false,"given":"Man-Hoon","family":"Han","sequence":"additional","affiliation":[{"name":"Department of Pathology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9867-0752","authenticated-orcid":false,"given":"Yong-Jin","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Pathology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0275-4960","authenticated-orcid":false,"given":"Seung","family":"Huh","sequence":"additional","affiliation":[{"name":"Department of Surgery, School of Medicine, Kyungpook National University, Kyungpook National University Hospital, Daegu, South Korea."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4648-0324","authenticated-orcid":false,"given":"Chan-Duck","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,5,28]]},"reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/j.1600-6143.2004.00360.x","article-title":"Predicting kidney graft failure by HLA antibodies: a prospective trial","volume":"4","author":"Terasaki","year":"2004","journal-title":"Am J Transplant"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1097\/TP.0000000000001231","article-title":"Anti-angiotensin II type 1 receptor and anti-endothelial cell antibodies: a cross-sectional analysis of pathological findings in allograft biopsies","volume":"101","author":"Philogene","year":"2017","journal-title":"Transplantation"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"e0222537","DOI":"10.1371\/journal.pone.0222537","article-title":"Excellent outcome after desensitization in high immunologic risk kidney transplantation","volume":"14","author":"Lim","year":"2019","journal-title":"PLoS One"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.kint.2017.06.034","article-title":"Angiotensin II Type 1 receptor antibodies are associated with inflammatory cytokines and poor clinical outcomes in pediatric kidney transplantation","volume":"93","author":"Pearl","year":"2018","journal-title":"Kidney Int"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1056\/NEJMoa035717","article-title":"Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection","volume":"352","author":"Dragun","year":"2005","journal-title":"N Engl J Med"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1097\/TP.0b013e3181fd97f1","article-title":"Anti-angiotensin type 1 receptor antibodies associated with antibody mediated rejection in donor HLA antibody negative patients","volume":"90","author":"Reinsmoen","year":"2010","journal-title":"Transplantation"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1111\/ajt.12397","article-title":"Pretransplant sensitization against angiotensin II type 1 receptor is a risk factor for acute rejection and graft loss","volume":"13","author":"Giral","year":"2013","journal-title":"Am J Transplant"},{"key":"R8-20250504","first-page":"1244","article-title":"The clinicopathological relevance of pretransplant anti-angiotensin II type 1 receptor antibodies in renal transplantation","volume":"32","author":"Lee","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1111\/tri.13009","article-title":"Is pre-transplant sensitization against angiotensin II type 1 receptor still a risk factor of graft and patient outcome in kidney transplantation in the anti-HLA Luminex era? A retrospective study","volume":"30","author":"Deltombe","year":"2017","journal-title":"Transpl Int"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.humimm.2017.03.012","article-title":"Assessing the potential of angiotensin II type 1 receptor and donor specific anti-endothelial cell antibodies to predict long-term kidney graft outcome","volume":"78","author":"Pinelli","year":"2017","journal-title":"Hum Immunol"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1053\/j.ajkd.2019.06.010","article-title":"Early antibody-mediated kidney transplant rejection associated with anti-vimentin antibodies: a case report","volume":"75","author":"Rampersad","year":"2020","journal-title":"Am J Kidney Dis"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1093\/ndt\/17.1.123","article-title":"Segmental infarction with graft dysfunction: an emerging syndrome in renal transplantation?","volume":"17","author":"Kanchanabat","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0140-6736(12)61265-3","article-title":"Antibody-mediated vascular rejection of kidney allografts: a population-based study","volume":"381","author":"Lefaucheur","year":"2013","journal-title":"Lancet"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1097\/MOT.0b013e3283636e55","article-title":"Non-HLA antibodies in solid organ transplantation: recent concepts and clinical relevance","volume":"18","author":"Dragun","year":"2013","journal-title":"Curr Opin Organ Transplant"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1111\/tri.12371","article-title":"The influence of non-HLA antibodies directed against angiotensin II type 1 receptor (AT1R) on early renal transplant outcomes","volume":"27","author":"Banasik","year":"2014","journal-title":"Transpl Int"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000025958","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T06:18:14Z","timestamp":1746339494000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000025958"}},"subtitle":["A case report and literature review"],"short-title":[],"issued":{"date-parts":[[2021,5,28]]},"references-count":15,"journal-issue":{"issue":"21","published-online":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000025958","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"type":"print","value":"0025-7974"},{"type":"electronic","value":"1536-5964"}],"subject":[],"published":{"date-parts":[[2021,5,28]]},"assertion":[{"value":"2021-03-03","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-04-28","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}